ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,000,677 | -4.6% | 297,755 | +26.6% | 0.05% | 0.0% |
| Q2 2023 | $8,387,696 | +25.8% | 235,213 | -10.4% | 0.05% | +4.4% |
| Q1 2023 | $6,665,747 | -39.7% | 262,431 | -3.6% | 0.04% | -51.1% |
| Q4 2022 | $11,046,435 | +81.7% | 272,348 | +48.0% | 0.09% | +41.5% |
| Q3 2022 | $6,080,000 | +33.5% | 183,967 | +42.2% | 0.06% | +54.8% |
| Q2 2022 | $4,556,000 | -24.7% | 129,388 | -1.6% | 0.04% | +16.7% |
| Q1 2022 | $6,050,000 | +17.4% | 131,557 | +69.3% | 0.04% | +33.3% |
| Q4 2021 | $5,153,000 | +69.5% | 77,725 | +59.6% | 0.03% | +28.6% |
| Q3 2021 | $3,040,000 | +24.8% | 48,701 | +65.6% | 0.02% | +40.0% |
| Q2 2021 | $2,436,000 | -19.8% | 29,408 | -35.8% | 0.02% | -28.6% |
| Q1 2021 | $3,036,000 | +214.3% | 45,792 | +263.8% | 0.02% | +133.3% |
| Q4 2020 | $966,000 | -62.5% | 12,587 | -78.9% | 0.01% | -71.0% |
| Q3 2020 | $2,573,000 | +104.0% | 59,745 | +104.7% | 0.03% | +72.2% |
| Q2 2020 | $1,261,000 | +530.5% | 29,188 | +319.7% | 0.02% | +125.0% |
| Q1 2020 | $200,000 | -94.7% | 6,954 | -88.2% | 0.01% | -86.2% |
| Q4 2019 | $3,744,000 | -38.6% | 59,029 | -72.7% | 0.06% | -38.9% |
| Q3 2019 | $6,099,000 | +38.3% | 216,441 | +30.1% | 0.10% | +21.8% |
| Q2 2019 | $4,409,000 | +17.7% | 166,391 | -18.5% | 0.08% | +30.0% |
| Q1 2019 | $3,746,000 | – | 204,150 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |